Conneqt HealthCQTHF 37 Buyback Yield % is -39.28 as of Jun. 28, 2026. GuruFocus rates CQTHF with a GF Score™ of 37/100 and a GF Value™ of $0.55. The stock has 8 warning signs investors should review. Among 346 Medical Devices & Instruments companies, Conneqt Health ranks worse than 90.46% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Conneqt Health's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CQTHF vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Conneqt Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conneqt Health Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conneqt Health's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Conneqt Health's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Conneqt Health (CQTHF) has a Buyback Yield % of -39.28 as of Jun. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Conneqt Health and its competitors. According to the industry distribution chart, Conneqt Health ranks #313 out of 346 companies in the Medical Devices & Instruments industry, placing it in the top 90.5%.
Is Conneqt Health's Buyback Yield % too high?
Conneqt Health's current Buyback Yield % is -39.28. Based on the distribution chart, Conneqt Health ranks #313 out of 346 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Conneqt Health has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Conneqt Health's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Conneqt Health ranks #313 out of 346 companies for Buyback Yield %. This places Conneqt Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Conneqt Health and its competitors. Conneqt Health's current Buyback Yield % is -39.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conneqt Health stock overvalued right now?
Conneqt Health (CQTHF) has a current Buyback Yield % of -39.28. The stock's GF Value™ is $0.55, compared to a current price of $0.40 — trading 27.3% below its estimated fair value. The current Buyback Yield % is -39.28. Conneqt Health's overall GF Score™ is 37/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Conneqt Health (CQTHF), the current Buyback Yield % is -39.28 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Conneqt Health (CQTHF) Overvalued in 2026?
Based on GuruFocus' analysis, Conneqt Health stock appears to be undervalued.
The current stock price of $0.40 is trading 27.3% below its estimated GF Value™ of $0.55.
Key valuation signals for CQTHF:
Buyback Yield %: -39.28
GF Value™: $0.55 vs. price of $0.40 (27.3% below fair value)
No single metric tells the full story. See the CQTHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Conneqt Health Ltd is a health technology company, developing solutions for health disorders. The company designs medical devices for use in cardiovascular health management. The company is mainly engaged in manufacturing biomarkers that helps to detect associated risks, optimize heart health, and empower good cardiovascular decisions.
37GF Score
Get the complete analysis for CQTHF
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CQTHF has been successfully added to your 
